Institutional investors purchased a net $9.0 million shares of AZN during the quarter ended September 2015, and now own 7.85% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 3.3 Million shares of AstraZeneca
WELLINGTON MANAGEMENT CO. LLP Bought 1.7 Million shares of AstraZeneca
CAMBIAR INVESTORS LLC Bought 1.4 Million shares of AstraZeneca